4586 Medrx
- 81
- +1+1.25%
Medrx News
Medrx: Notice of termination of joint research agreement with FunPep Co., Ltd.
Medrx: Notice regarding the monthly exercise status of the 29th Stock Acquisition Rights (with exercise price amendment clause) issued by third party allotment
Medrx: Notice regarding the recording of non-operating expenses
Medrx: Notice regarding the monthly exercise status of the 29th Stock Acquisition Rights (with exercise price amendment clause) issued by third party allotment
Medrx: Notice of commencement of MRX-7MLL clinical trials
Medrx: Notice regarding the monthly exercise status of the 29th Stock Acquisition Rights (with exercise price amendment clause) issued by third party allotment
Medrx: Notice Concerning Mass Exercise of the 29th Stock Acquisition Rights (with Exercise Price Amendment Clauses) Issued by Third Party Allotment
Medrx: Notice regarding the Reiwa 6th SME Overseas Expansion Support Project Cost Subsidy (Overseas Application Support Project) Indirect Subsidy Grant Decision
Medrx: Notice of Patent Assessment (Japan) relating to MRX-4TZT
Medrx: Notice regarding the monthly exercise status of the 29th Stock Acquisition Rights (with exercise price amendment clause) issued by third party allotment
Medrx: Announcement of the massive exercise of the 29th subscription rights (with an exercise price adjustment clause) issued by third-party allotment.
Medrx: Announcement of the massive exercise of the 29th subscription rights (with an exercise price adjustment clause) issued by third-party allotment.
Medrx: Announcements of individual stocks regarding the recognition of non-operating income, non-operating expenses and special profits
Medrx: Announcements of individual stocks regarding the monthly exercise status of the 29th subscription rights (with exercise price adjustment clause) issued through a third-party allocation.
Medrx: Announcement of the massive exercise of the 29th subscription rights (with an exercise price adjustment clause) issued by third-party allotment.
Medrx: Announcements of individual stocks regarding the decision to provide indirect subsidies for the overseas application support business subsidy program for SMEs and others in overseas expansion support project expenses for fiscal 2024.
Medrx: Regarding the policy towards reapplying for MRX-5LBT
Medrx: Announcements of individual stocks: Notification of completion report received for MRX-5LBT review.
Medrx: Announcement of the massive exercise of the 29th subscription rights (with an exercise price adjustment clause) issued by third-party allotment.
Medrx: Announcements of individual stocks regarding the monthly exercise status of the 29th subscription rights (with exercise price adjustment clause) issued through a third-party allocation.
No Data